Skip to main content

MoneyWorks4Me

Divis Laboratories board to consider unaudited financial results

23 Jan 2013 Evaluate

Divis Laboratories has informed that a meeting of the board of directors of the company will be held on February 02, 2013, to consider and approve, the un-audited financial results for the third quarter ended December 31, 2012 (Q3).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..